CVS vs LEXXW · P/E 16, rev $106.10B vs rev $705.9K
CVS Health Corp (CVS) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Latest reported CVS revenue for 2026-06-30 was $106.10B. Net income was $2.98B. Revenue was up 5.6% from 2026-03-31 to 2026-06-30. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the CVS and LEXXW stock pages for the full models.
Not investment advice.